These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1149007)

  • 1. "Platinum-pyrimidine blues" and related complexes: a new class of potent antitumor agents.
    Davidson JP; Faber PJ; Fischer RG; Mansy S; Peresie HJ; Rosenberg B; VanCamp L
    Cancer Chemother Rep; 1975; 59(2 Pt 1):287-300. PubMed ID: 1149007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor properties of pyrazolo [3,4-D] pyrimidine derivatives.
    Witkiewicz K; Machoń Z; Mordarski M; Wieczorek J
    Pol J Pharmacol Pharm; 1987; 39(6):715-20. PubMed ID: 3503990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordination complexes of platinum as antitumor agents.
    Speer RJ; Ridgway H; Hall LM; Stewart DP; Howe KE; Lieberman DZ; Newman AD; Hill JM
    Cancer Chemother Rep; 1975; 59(3):629-41. PubMed ID: 1203887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposoluble platinum(II) complexes with antitumor activity.
    Maeda M; Uchida NA; Sasaki T
    Jpn J Cancer Res; 1986 Jun; 77(6):523-5. PubMed ID: 3015851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isothiazolopyrimidines--new group of anticancer agents. I.
    Machoń Z; Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum complexes of substituted ethylenediamines and their anti-tumour activity.
    Beaumont KP; McAuliffe CA; Cleare MJ
    Chem Biol Interact; 1976 Jul; 14(1-2):179-93. PubMed ID: 954137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antineoplastic activity of complex compounds of platinum(IV)].
    Presnov MA; Zheligovskaia NN; Babkov AV; Konovalova AL; Budanova NS
    Dokl Akad Nauk SSSR; 1976 JUL-AUG; 229(1):226-9. PubMed ID: 954573
    [No Abstract]   [Full Text] [Related]  

  • 10. Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogs.
    Prestayko AW; Bradner WT; Huftalen JB; Rose WC; Schurig JE; Cleare MJ; Hydes PC; Crooke ST
    Cancer Treat Rep; 1979; 63(9-10):1503-8. PubMed ID: 498150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinostatic effect of caffeine-8-ether-platinum-complexes].
    Kröger H; Klosa J
    Naturwissenschaften; 1981 Dec; 68(12):628. PubMed ID: 7335120
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis, chemical characterization and biological evaluation of new platinum (II)-sulfonamide complexes.
    Craciunescu DG; Scarcia V; Furlani A; Parrondo Iglesias E; Ravalico L; Doadrio A
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):183-7. PubMed ID: 2334458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor action of cis-dichlorodiammineplatinum(II) and the effectiveness of a combination with sarcolysine].
    Presnov MA; Konovalova AL; Romanova LF; Sof'ina ZP; Stetsenko AI
    Vopr Onkol; 1978; 24(4):53-60. PubMed ID: 654174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of cyclocytidine in a variety of tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
    [No Abstract]   [Full Text] [Related]  

  • 15. Platinum compounds: a new class of potent antitumour agents.
    Rosenberg B; VanCamp L; Trosko JE; Mansour VH
    Nature; 1969 Apr; 222(5191):385-6. PubMed ID: 5782119
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH; al-Baker S; Thai G; Khokhar AR
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
    Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
    Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y; Arai Y; Taguchi H; Satoh H
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.
    Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR
    Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor action of cis-dichlorobis(methylamine)platinum(II).
    Gale GR; Rosenblum MG; Atkins LM; Walker EM; Smith AB; Meischen SJ
    J Natl Cancer Inst; 1973 Oct; 51(4):1227-34. PubMed ID: 4583374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.